Cork employees raise €20,000 for cancer research charity
The impressive sum of money was raised by Ask Acorn employees through the annual Environmental, Social and Governance (ESG) programme.
Ask Acorn are a nationwide financial intermediary and distributor of life protection products who have offices on the Airport Road in Cork city.
The funds will directly support research into poorer prognosis cancers, with a five-year survival of less than 25% and currently very limited treatment options.
Currently, nearly half (45%) of all cancer deaths in Ireland come from seven low survival cancers, and these are the cancers Breakthrough Cancer Research is currently targeting their research towards.
Breakthrough was selected through a company-wide nomination process, with employees putting forward causes that hold personal meaning.
The strong support for Breakthrough Cancer Research reflects the fact that one in two people in Ireland will face a cancer diagnosis in their lifetime — a reality that has touched many within the Ask Acorn team.
Breakthrough Cancer Research is dedicated to funding scientific research that targets the most urgent gaps in cancer treatment, particularly where options are limited and outcomes remain poor.
Their work helps drive progress in cancers that are currently under-funded, offering hope where it's needed most.
Orla Dolan CEO of Breakthrough Cancer Research said the donation will go directly towards cutting-edge research into the lowest survival cancers which urgently need more investment. 'Every donation brings us closer to a future free from cancer, where no one ever hears the words, 'There's nothing left to try.'
The organisation supports cutting-edge, patient-focused research across Ireland, including projects at the University College Cork, Cork University Hospital, Bon Secours Cork and MTU.
These include advances in overcoming treatment resistance, earlier detection through identification new biomarkers, next-gen immunotherapy and personalised medicine through initiatives like Precision Oncology Ireland.
'At Ask Acorn, protection is at the core of what we do,' said Vivian O Callaghan and Jim Landy, Branch Managers in Cork City for Ask Acorn. 'Many of us have experienced the impact of cancer up close and we're proud to help fund research that offers real hope to patients and families across the country.'
Monies raised for Breakthrough Cancer directly fund new treatment discoveries, clinical trials, and innovations that could dramatically improve outcomes for people diagnosed with difficult-to-treat cancers.
The charity has a bold vision: 100% survival for 100% of cancers.
To find out more or to support Breakthrough Cancer Research see www.breakthroughcancerresearch.ie or @breakthrocancer on social media.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
a day ago
- Irish Examiner
Waste management firm Chemishield to create 50 new Irish jobs
Chemical waste management company Chemishield has announced the creation of 50 new roles across its Irish operations. The jobs will be filled in the next 18 months, the company has said, and will support Chemishield's next phase of growth which will include its expansion into North America. As well as its geographical expansion, the company is also aiming for increased customer acquisition and new product development. The company has also announced that Malcolm Bell, the CEO of Envetec Sustainable Technologies, has made a strategic investment in the company and joined its board of directors. The investment represents an important new phase for Chemishield, with firm said, with Mr Bell boasting "an impressive track record in businesses such as healthcare, life sciences, and sustainability." 'Malcolm's decision to join Chemishield highlights the scale of the opportunity ahead,' said Kevin Walsh, founder and CEO of Chemishield. 'We are changing how chemical and lab waste is managed at its source, and Malcolm's strategic insight, proven track record, and experience scaling companies will be essential as we grow our platform and expand our partnerships. Over the next 18 months, we expect to onboard up to 50 FTEs across sales, support and tech.' Chemishield's cloud-based platform replaces older manual systems with digital tools that automate waste classification, regulatory labelling, and compliance reporting. The software helps organisations reduce risk, cut costs, and meet ESG goals while supporting broader digital transformation agendas. 'Chemishield sits at the intersection of safety, sustainability, and digital transformation," said Malcolm Bell, founder and CEO of Envetec. 'With rising demand across essential industries, Chemishield is uniquely positioned to scale and set a new benchmark for compliance, safety, and operational efficiency.' In addition to its expansion, the company is also exploring white-label opportunities with global environmental service providers. Chemishield focuses on key sectors, including pharmaceuticals, healthcare, life sciences, and food and beverages. Its waste segregation module is the first of its kind, enabling environmental, health and safety, and lab teams to eliminate errors at the source while enhancing data capture and waste stream traceability.
Irish Independent
29-05-2025
- Irish Independent
‘She was a ray of sunshine' — Mini Marathon runners honour memory of a young woman lost to rare cancer
They are doing so in memory of Eve McMahon, a 23-year-old woman from Kildare whose life was cut tragically short by a rare form of cancer. Eve's sister Lucy and her best friend Ellen Redmond are behind the Run for Eve fundraiser, which is once again supporting Sarcoma Cancer Ireland. The small, volunteer-run charity offers vital support to patients and families affected by sarcoma, a rare and aggressive form of cancer that typically affects children and young adults. Eve was just 22 when she was diagnosed with alveolar rhabdomyosarcoma in October 2021. Despite enduring months of intensive treatment at St Vincent's Private Hospital, she died eight months later on June 19, 2022, just three days after her 23rd birthday. Ellen described the annual run as a way of 'keeping Eve's memory alive', while also channelling grief into something positive. 'I just thought, wouldn't it be lovely to bring everyone together, her family, friends, neighbours, to do something uplifting around the time of her anniversary,' Ellen said. 'It's a very emotional time of year for all of us, but the mini marathon gives us a reason to come together in her name.' The first Run for Eve took place in 2023 and raised over €30,000 for Sarcoma Cancer Ireland, which at the time had only just begun establishing itself as a registered charity. Last year, the group raised nearly €20,000 for Breakthrough Cancer Research, chosen because Eve, a science graduate, had been studying for a master's in epidemiology at Imperial College London when she fell ill. 'Eve was the kind of person who would have gone into research herself. She was so smart, so driven, so that felt like a really fitting cause,' Ellen said. This year, the group will once again support Sarcoma Cancer Ireland, who, Ellen notes, 'don't receive any government funding'. The charity relies entirely on public donations to fund services such as counselling, treatment support, and small comforts for patients undergoing chemotherapy. Now in its third year, what started as a close-knit group of about 20 runners has swelled to over 40 participants last year, with even more expected this June. 'It's incredible how many people have gotten involved, friends of friends, people we've never even met, aunties, cousins, all just wanting to do something positive in Eve's name,' Ellen said. At the heart of the campaign is the memory of a bright, kind, and multi-talented young woman, a talented piano player and teacher, an avid cook who ran a food blog, and someone who dabbled in everything from crochet to leadership roles. 'She was one of those people who was just good at everything,' Ellen said. 'Everyone loved her, she was a ray of sunshine, honestly. And she never complained, not once. Even when she got sick, she just did everything the doctors told her. She never asked, 'Why me?' She just got on with it.' For Ellen, the mini marathon has become a way to keep that spirit alive. 'I get to see her cousins each year, her college friends, people I mightn't have crossed paths with otherwise. It keeps us all connected, and it keeps Eve close,' Ellen said. 'That's what matters most.' To donate to this year's campaign or join the team, visit the Run for Eve GoFundMe page.
Irish Independent
29-05-2025
- Irish Independent
Cork employees raise €20,000 for cancer research charity
The impressive sum of money was raised by Ask Acorn employees through the annual Environmental, Social and Governance (ESG) programme. Ask Acorn are a nationwide financial intermediary and distributor of life protection products who have offices on the Airport Road in Cork city. The funds will directly support research into poorer prognosis cancers, with a five-year survival of less than 25% and currently very limited treatment options. Currently, nearly half (45%) of all cancer deaths in Ireland come from seven low survival cancers, and these are the cancers Breakthrough Cancer Research is currently targeting their research towards. Breakthrough was selected through a company-wide nomination process, with employees putting forward causes that hold personal meaning. The strong support for Breakthrough Cancer Research reflects the fact that one in two people in Ireland will face a cancer diagnosis in their lifetime — a reality that has touched many within the Ask Acorn team. Breakthrough Cancer Research is dedicated to funding scientific research that targets the most urgent gaps in cancer treatment, particularly where options are limited and outcomes remain poor. Their work helps drive progress in cancers that are currently under-funded, offering hope where it's needed most. Orla Dolan CEO of Breakthrough Cancer Research said the donation will go directly towards cutting-edge research into the lowest survival cancers which urgently need more investment. 'Every donation brings us closer to a future free from cancer, where no one ever hears the words, 'There's nothing left to try.' The organisation supports cutting-edge, patient-focused research across Ireland, including projects at the University College Cork, Cork University Hospital, Bon Secours Cork and MTU. These include advances in overcoming treatment resistance, earlier detection through identification new biomarkers, next-gen immunotherapy and personalised medicine through initiatives like Precision Oncology Ireland. 'At Ask Acorn, protection is at the core of what we do,' said Vivian O Callaghan and Jim Landy, Branch Managers in Cork City for Ask Acorn. 'Many of us have experienced the impact of cancer up close and we're proud to help fund research that offers real hope to patients and families across the country.' Monies raised for Breakthrough Cancer directly fund new treatment discoveries, clinical trials, and innovations that could dramatically improve outcomes for people diagnosed with difficult-to-treat cancers. The charity has a bold vision: 100% survival for 100% of cancers. To find out more or to support Breakthrough Cancer Research see or @breakthrocancer on social media.
